Bipolar Disorder: Clinical Trials

12 trials for Bipolar Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 withdrawn. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Withdrawn 12

Follow Bipolar Disorder: new trials by email Literature Review of Bipolar Disorder trials Research Report on Bipolar Disorder

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dopamine D3 Receptor Occupancy in Bipolar Depression
Cariprazine - Bipolar Depression
Phase 4WithdrawnNew York State Psychiatric Institute2026-01-062026-04-14
Pilot Study 1: Efficacy and Safety of Sublingual Dexmedetomidine (BXCL501) for the Treatment of Agitation in the Emergency Department
Sublingual film containing dexmedetomidine (BXCL501) - Agitation, Schizophrenia
Phase 4WithdrawnBrigham and Women's Hospital2023-09-012026-01-28
A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid
Ethyl Eicosapentaenoic Acid - Bipolar Disorder
Phase 4WithdrawnNew York State Psychiatric Institute2021-03-192022-10-14
Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia
Suvorexant (Belsomra), Placebo - Bipolar Disorder, Insomnia
Phase 4WithdrawnMassachusetts General Hospital2019-02-262021-02-21
A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
N-acetylcysteine, Minocycline, Placebo - Bipolar Disorder, Bipolar Depression
Phase 4WithdrawnMassachusetts General Hospital2017-08-092026-07-24
Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
Latuda (Lurasidone) - Mania, Bipolar I
Phase 4WithdrawnMassachusetts General Hospital2017-01-012018-07-20
Neural Correlates for Therapeutic Mechanisms of Lithium in Bipolar Disorder
Lithium - Bipolar Disorder
Phase 4WithdrawnEwha Womans University2015-06-012018-02-09
Lithium Versus Paroxetine in Major Depression
Lithium, Paroxetine - Major Depressive Disorder
Phase 4WithdrawnNova Scotia Health Authority2011-09-012024-09-19
Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by Alcoholism
Paliperidone Palmitate, Placebo - Bipolar Disorder
Phase 4WithdrawnUniversity of Miami2010-10-012014-11-21
Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression
Quetiapine fumarate, Divalproex sodium - Bipolar Depression
Phase 4WithdrawnBo-Hyun Yoon2010-08-012012-04-27
Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder
Depakote, Lithium - Bipolar Disorder
Phase 4WithdrawnLawson, William B., M.D., PhD, DFAPA502006-12-012010-02-24
An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder
divalproex or olanzapine - Bipolar Disorder
Phase 4WithdrawnMayo Clinic2015-06-01

Narrower conditions

Alcoholism (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Mania (1)  ·  Psychomotor Agitation (1)  ·  Psychotic Disorders (1)  ·  Schizophrenia (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Broader conditions

Bipolar and Related Disorders (12)  ·  Mental Disorders (12)  ·  Mood Disorders (12)  ·  Nervous System Diseases (3)  ·  Behavior (2)  ·  Behavioral Symptoms (2)  ·  Neurobehavioral Manifestations (2)  ·  Neurologic Manifestations (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Alcohol-Related Disorders (1)  ·  Chemically-Induced Disorders (1)  ·  Depressive Disorder (1)  ·  Dyskinesias (1)

Interventions

Lithium (3)  ·  Valproic Acid (3)  ·  Acetylcysteine (1)  ·  Docosahexaenoic Acids (1)  ·  Lithium Carbonate (1)  ·  Lurasidone Hydrochloride (1)  ·  Minocycline (1)  ·  Olanzapine (1)  ·  Paliperidone Palmitate (1)  ·  Paroxetine (1)  ·  Quetiapine Fumarate (1)  ·  cariprazine (1)  ·  eicosapentaenoic acid ethyl ester (1)  ·  suvorexant (1)

Sponsors

Massachusetts General Hospital (3)  ·  New York State Psychiatric Institute (2)  ·  Bo-Hyun Yoon (1)  ·  Brigham and Women's Hospital (1)  ·  Ewha Womans University (1)  ·  Lawson, William B., M.D., PhD, DFAPA (1)  ·  Mayo Clinic (1)  ·  Nova Scotia Health Authority (1)  ·  University of Miami (1)

Countries

United States (6)  ·  South Korea (2)  ·  Canada (1)

Top investigators

Andrew A Nierenberg, M.D. (1)  ·  Bo-Hyun Yoon, Doctor (1)  ·  Claire O'Donovan, MD, FRCPC (1)  ·  Gustavo Kinrys, MD (1)  ·  Ihsan Salloum, MD MPH (1)  ·  Janet Wozniak, M.D. (1)  ·  Mark A Frye, MD (1)  ·  Martin Lan, MD (1)  ·  William B. Lawson, MD, PhD (1)